EVO (evotec.com) Enterprise Value-to-Revenue Coefficient

Official company branding of Evotec (EVO)

Despite demand volatility risks in the biotech sector, Evotec SE (EVO) relies on the strong human capital of world-class scientists. The enterprise value-to-annual revenue multiple visualizes the market valuation, while the 727.12 metric confirms the current level. The high scalability of platform technologies accelerates the launch of new projects, consistently increasing the overall profitability of the business.

Evotec SE (EVO): EV/Sales Multiple from 11/23/2025 to 11/20/2026

EVO (Evotec Group): analytical breakdowns and indicator data

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:EVO, Evotec SE
Product sample of Evotec Corp

This multiple reflects the market value of the business, including net debt, per unit of revenue. By analyzing the Enterprise Value to Sales ratio, an investor determines the extent of the premium paid for operating results. The metric compares the total cost of acquiring the company with its annual turnover. For Evotec SE (EVO), this indicator is critical during the transition to high-margin biomanufacturing. Cost optimization should lead to increased efficiency for every unit of revenue.